Pharmaceutical Industry Information Portal

HomeNews

News

Moderna fell, Novavax rose – positive vaccine news caused mixed reactions

Moderna stock and Novavax stock suffered contrasting fortunes in premarket trading on Wednesday after positive updates for both companies regarding their COVID-19 vaccines. Moderna stock...

3D deep-learning research company Charm Therapeutics launches with $50m series A

CHARM Therapeutics (“CHARM”, “The Company”), announces today a $50M Series A financing co-led by F-Prime Capital and OrbiMed, with General Catalyst, Khosla Ventures, Braavos...

Bavarian Nordic expects new orders for monkeypox vaccine due to strong interest

Biotechnology company Bavarian Nordic (BAVA.CO) expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from governments around the world, its...

Code Biotherapeutics raises $75 Million to advance programs to treat and cure rare and prevalent genetic diseases

Code Biotherapeutics, Inc., (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized and oversubscribed Series A financing...

Novavax’s COVID-19 vaccine received FDA AdCom approval, clearing “serious hurdles”

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, Tuesday announced the U.S. Food and Drug Administration...

AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from...
spot_img

Expert Articles

spot_img